Cetera Investment Advisers
PROF

Cetera Investment Advisers’s Profound Medical PROF Stock Holding History

Cetera Investment Advisers’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11,619
Closed -$92.5K – 3867
2024
Q3 		$92.5K Sell
11,619
-150
-1% -$1.35K ﹤0.01% 3551
2024
Q2 		$101K Hold
11,769
– – ﹤0.01% 3512
2024
Q1 		$100K Buy
+11,769
New +$98.2K ﹤0.01% 3500

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Cetera Investment Advisers's PROF Position: Q4 2024 in Review

Cetera Investment Advisers sold out of Profound Medical (PROF) in Q4 2024, closing a stake of 11,619 shares — an estimated $92.5K sold.

Cetera Investment Advisers first reported a position in PROF in Q1 2024 and held it in 3 quarters. The position peaked at $101K in Q2 2024. 52 funds tracked by Wall St. Rank hold PROF as of Q4 2024.

  • Cetera Investment Advisers reported no remaining Profound Medical position as of Q4 2024 after selling out during the quarter.
  • Cetera Investment Advisers sold 11,619 Profound Medical shares in Q4 2024, an estimated $92.5K.
  • Cetera Investment Advisers first reported a position in Profound Medical in Q1 2024 and held it in 3 quarters.
  • Cetera Investment Advisers's Profound Medical position peaked at $101K in Q2 2024.
  • 52 funds tracked by Wall St. Rank held Profound Medical as of Q4 2024.

Based on Cetera Investment Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.